多采样点剪切波弹性成像评估肥胖代谢功能障碍相关脂肪性肝病患者的肝纤维化
本研究以肝活检为参考标准,回顾性分析241例肥胖合并代谢功能障碍相关脂肪性肝病(MASLD)患者,评估多采样点剪切波弹性成像(pSWE)对肝纤维化的诊断效能,并与FIB-4指数和APRI比较。结果显示Auto-pSWVs与肝纤维化病理诊断正相关(r=0.34,p<0.001),对显著纤维化(≥F2)和进展期纤维化(≥F3)的诊断效能优于FIB-4和APRI(p<0.05),AUC分别为0.75(95%CI 0.66-0.85)和0.96(95%CI 0.89-1.0),cut-off值分别为≥1.02 m/s和≥1.30 m/s。结论认为多采样点pSWE似乎是诊断肥胖MASLD患者肝纤维化的有价值工具。
要点
- Auto-pSWVs诊断≥F2的AUC为0.75(95%CI 0.66-0.85),cut-off值为≥1.02 m/s。
- Auto-pSWVs诊断≥F3的AUC为0.96(95%CI 0.89-1.0),cut-off值为≥1.30 m/s。
- Auto-pSWVs对≥F2和≥F3的诊断效能均优于FIB-4指数和APRI(p<0.05)。
核心结论
- 多采样点pSWE似乎是诊断肥胖MASLD患者肝纤维化的有价值工具。
研究设计与样本
- 回顾性单中心研究,纳入2023年4月至2024年12月间符合MASLD诊断标准的肥胖患者241例,以肝活检为参考标准,采用多采样点pSWE技术测量Auto-pSWVs(m/s),并与FIB-4指数和APRI比较诊断效能。
诊断标准与关键数值
- Auto-pSWVs诊断显著纤维化(≥F2)的AUC为0.75(95%CI 0.66-0.85),cut-off值为≥1.02 m/s。
- Auto-pSWVs诊断进展期纤维化(≥F3)的AUC为0.96(95%CI 0.89-1.0),cut-off值为≥1.30 m/s。
- Auto-pSWVs对≥F2和≥F3的诊断效能均优于FIB-4指数和APRI(p<0.05)。
- Auto-pSWVs与肝纤维化病理诊断正相关(r=0.34,p<0.001),肝纤维化分期是Auto-pSWVs的独立危险因素(beta系数:0.42,p<0.001)。
临床应用与阅片要点
- 在肥胖MASLD患者中,可以肝活检为参考,采用多采样点pSWE测量的Auto-pSWVs评估肝纤维化分期。
- Auto-pSWVs≥1.02 m/s对应显著纤维化(≥F2),≥1.30 m/s对应进展期纤维化(≥F3)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To evaluate the diagnostic performance of multisample point shear wave elastography (pSWE) for liver fibrosis in obese patients with metabolic dysfunction-associated steatotic liver disease (MASLD) using liver biopsy as the reference standard and to compare it with the FIB-4 index and aspartate to platelet ratio index (APRI).
METHODS: Patients with obesity who met the diagnostic criteria for MASLD between April 2023 and December 2024 were selected for this retrospective single-centre study. Liver stiffness measurements were reported as median values of measurements, and Auto-pSWVs (m/s) were measured using the multisample pSWE technique. The diagnostic performance of auto shear wave velocities (Auto-pSWVs), FIB-4 index and APRI for significant fibrosis (≥F2) and advanced fibrosis (≥F3) of the liver was evaluated and compared using receiver operating characteristic curves with liver biopsy as the criterion. The correlation between Auto-pSWVs and the clinical variables of the subjects was evaluated.
RESULTS: Data from 241 patients were analysed. Auto-pSWVs were positively correlated with the pathological diagnosis of liver fibrosis (r=0.34, p<0.001), and the liver fibrosis stage was an independent risk factor for Auto-pSWVs (beta coefficient: 0.42, p< 0.001). In addition, Auto-pSWVs was superior to FIB-4 index and APRI when comparing the diagnostic performance of significant liver fibrosis (≥F 2) and advanced fibrosis (≥F3) (p < 0.05). The AUC of Auto-pSWVs was 0.75 (95% CI 0.66-0.85) and 0.96 (95% CI 0.89-1.0) in the ≥ F2 and ≥ F3 groups, respectively. The cut-off value for Auto-pSWVs were determined as follows: grade F2 ≥ 1.02 m/s; and grade F3 ≥ 1.30 m/s.
CONCLUSION: Multisample pSWE appears to be a valuable tool for the diagnosis of liver fibrosis in obese patients with MASLD.
引用
- Sun M, Zhong M, Luo F, et al. Assessment of Liver Fibrosis with Multisample Point Shear Wave Elastography in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Acad Radiol. 2025. PMID: 40393826. doi:10.1016/j.acra.2025.04.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。